Novartis AG - 22 Year Stock Price History | NVS

Historical daily share price chart and data for Novartis AG since 1996 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Novartis AG as of November 15, 2018 is 87.24.
Novartis AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 81.6206 81.7361 90.6452 72.4400 87.2400 7.65%
2017 77.3285 67.8627 83.6376 65.2536 81.0412 19.40%
2016 71.1043 76.9382 77.8142 62.9801 67.8720 -12.08%
2015 86.9221 80.5042 95.2150 75.3322 77.1984 -4.53%
2014 76.4988 66.4745 84.3439 66.0354 80.8620 19.13%
2013 61.4015 51.9324 67.8847 51.8267 67.8763 31.80%
2012 46.4988 45.3107 52.0382 41.8844 51.5012 15.67%
2011 44.4192 44.2387 50.2483 40.2251 44.5241 1.14%
2010 39.4060 37.9000 44.6345 32.6936 44.0221 12.27%
2009 31.9808 34.1752 40.4574 24.4646 39.2111 14.23%
2008 35.4352 36.5726 42.1223 30.2500 34.3270 -5.69%
2007 37.0950 38.2379 39.5617 34.5821 36.3984 -3.65%
2006 36.9948 34.5857 40.2768 34.1340 37.7775 11.29%
2005 32.0315 31.9602 35.3813 29.5922 33.9454 5.64%
2004 29.1581 28.6697 32.1827 26.2573 32.1318 12.10%
2003 24.3293 22.7333 28.6634 21.1647 28.6634 27.36%
2002 23.8494 21.6449 26.8572 20.7438 22.5066 1.96%
2001 23.0782 26.7299 26.8433 19.9455 22.0743 -17.31%
2000 21.5098 20.8904 26.6941 17.1947 26.6941 26.91%
1999 22.5089 29.4012 29.6853 20.0634 21.0340 -24.44%
1998 24.2310 23.2010 28.6200 20.5240 27.8388 21.46%
1997 19.7957 15.0993 23.8009 14.4385 22.9193 50.81%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $204.655B $49.109B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $388.162B 18.20
Pfizer (PFE) United States $259.069B 14.60
Merck (MRK) United States $201.163B 17.43
AbbVie (ABBV) United States $132.702B 11.78
Eli Lilly (LLY) United States $119.057B 20.93
Sanofi (SNY) France $112.613B 13.94
Novo Nordisk (NVO) Denmark $107.980B 17.54
AstraZeneca (AZN) United Kingdom $105.090B 13.05
GlaxoSmithKline (GSK) United Kingdom $102.669B 13.80
Bristol-Myers Squibb (BMY) United States $85.837B 14.14